Pyridoxine-Dependent Epilepsy and Antiquitin Deficiency Resulting in Neonatal-Onset Refractory Seizures
Open Access
- 31 December 2021
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 12 (1) , 65
Abstract
Pyridoxine-dependent epilepsy (PDE) is an autosomal recessive neurometabolic disorder due to a deficiency of α-aminoadipic semialdehyde dehydrogenase (mutation in ALDH7A1 gene), more commonly known as antiquitin (ATQ). ATQ is one of the enzymes involved in lysine oxidation; thus, its deficiency leads to the accumulation of toxic metabolites in body fluids. PDE is characterized by persistent, recurrent neonatal seizures that cannot be well controlled by antiepileptic drugs but are responsive clinically and electrographically to daily pyridoxine (vitamin B6) supplementation. Although the phenotypic spectrum distinguishes between typical and atypical, pyridoxine-dependent is true for each. Diagnosis may pose a challenge mainly due to the rarity of the disorder and the fact that seizures may not occur until childhood or even late adolescence. Moreover, patients may not demonstrate an obvious clinical or electroencephalography response to the initial dose of pyridoxine. Effective treatment requires lifelong pharmacologic supplements of pyridoxine, and dietary lysine restriction and arginine enrichment should improve prognosis and avoid developmental delay and intellectual disability. The purpose of this review is to summarize briefly the latest reports on the etiology, clinical symptoms, diagnosis, and management of patients suffering from pyridoxine-dependent epilepsy.Keywords
This publication has 58 references indexed in Scilit:
- Normal plasma pipecolic acid level in pyridoxine dependent epilepsy due to ALDH7A1 mutationsMolecular Genetics and Metabolism, 2013
- The measurement of urinary Δ1‐piperideine‐6‐carboxylate, the alter ego of α‐aminoadipic semialdehyde, in Antiquitin deficiencyJournal of Inherited Metabolic Disease, 2012
- The genotypic and phenotypic spectrum of pyridoxine‐dependent epilepsy due to mutations in ALDH7A1Journal of Inherited Metabolic Disease, 2010
- Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)Brain, 2010
- Antenatal treatment in two Dutch families with pyridoxine-dependent seizuresEuropean Journal of Pediatrics, 2009
- α-Aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by α-aminoadipic semialdehyde dehydrogenase deficiencyMolecular Genetics and Metabolism, 2007
- Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levelsArchives of Disease in Childhood, 2007
- Pyridoxine‐dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regimeDevelopmental Medicine & Child Neurology, 2007
- Pyridoxal 5′‐phosphate may be curative in early‐onset epileptic encephalopathyJournal of Inherited Metabolic Disease, 2006
- Hyperphosphatasia With Neurologic Deficit: A Pyridoxine-Responsive Seizure Disorder?Pediatric Neurology, 2006